Skip to main navigation Skip to search Skip to main content

Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial

  • Marc Cohen
  • , Glenn Levine
  • , Karen Pieper
  • , Lan Lan
  • , Elliott Antman
  • , Philip Aylward
  • , Harvey White
  • , Neal Kleiman
  • , Robert Califf
  • , Kenneth Mahaffey

    Research output: Contribution to journal › Article › peer-review

    19 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial'. Together they form a unique fingerprint.
    Sort by

    Pharmacology, Toxicology and Pharmaceutical Science